Virpax Pharmaceuticals
Biotechnology
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

$816.6K

Market Cap • 4/3/2025

2017

(8 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Berwyn

Headquarters • Pennsylvania